Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact?

  • Guo Y
  • Pisters R
  • Apostolakis S
 et al. 
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

BACKGROUND: The risk of stroke associated with atrial fibrillation (AF) is higher in Far Eastern population than in Western population, and warfarin use suboptimal. There is uncertainty whether the novel oral anticoagulants (NOACs) would have a major impact on stroke prevention in Far Eastern populations with AF. OBJECTIVES: We investigated current antithrombotic therapy use on stroke and bleeding risk, determinants of warfarin use and performed a modeling analysis of the net clinical benefit of the NOACs (apixaban, dabigatran) in a large cohort of Chinese patients with AF. METHODS: We studied 1034 Chinese patients (27.1% female, median age 75years, interquartile range [IQR]: 63-83) with AF who were followed-up for an average of 1.9years (IQR: 1.43-2.64). Stroke/thromboembolism (TE), and major bleeding associated to antithrombotic treatment were investigated. A modeling analysis was performed for the net clinical benefit balancing major bleeding against stroke/TE for dabigatran 110mg bid, dabigatran 150mg bid and apixaban, using their respective recent clinical trial outcome data. RESULTS: Using a Cox proportional hazard model, the Hazard Ratio [HR (95% confidence interval, CI)] for stroke/TE compared to no-antithrombotic therapy (no ATT) was 1.27 (0.65-2.50) on aspirin, 1.40 (0.35-3.57) on clopidogrel, 1.52 (0.72-3.23) on dual antiplatelets and 1.65 (0.76-3.57) on warfarin. The risk for major bleeding was 0.35 (0.14-0.85) on aspirin, 0.74 (0.24-2.29) on clopidogrel, 0.35 (0.11-1.10) on dual antiplatelets, and 0.88 (0.36-2.17) on warfarin. Binary logistic regression analysis showed persistent/permanent AF (Odds Ratio, OR, 2.03 [95%CI 1.05-3.92], p=0.035) was associated with warfarin use, but age >/=75years (0.26 [0.16-0.42], p

Author-supplied keywords

  • Anticoagulants
  • Atrial Fibrillation
  • Female
  • Stroke
  • Thrombosis
  • Warfarin
  • methods

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PMID: 23103146

Authors

  • Y Guo

  • R Pisters

  • S Apostolakis

  • A D Blann

  • H Wang

  • X Zhao

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free